remdesivir
Showing 26 - 50 of 54
Covid19 Trial in Italy (Baricitinib Oral Tablet [Olumiant], Remdesivir, Dexamethasone)
Not yet recruiting
- Covid19
- Baricitinib Oral Tablet [Olumiant]
- +2 more
-
Ancona, Italy
- +20 more
Apr 3, 2021
COVID-19 Trial in Worldwide (Remdesivir)
Recruiting
- COVID-19
- Remdesivir
-
Birmingham, Alabama
- +36 more
Aug 18, 2022
Covid19, SARS-CoV Infection, Corona Virus Infection Trial in London (SARS-CoV-2 Virus, Remdesivir)
Completed
- Covid19
- +4 more
- SARS-CoV-2 Virus
- Remdesivir
-
London, United Kingdom
- +1 more
Jul 27, 2022
Covid19, Covid-19 ARDS Trial in Dinajpur (Remdesivir, Baricitinib, Tocilizumab)
Recruiting
- Covid19
- Covid-19 ARDS
- Remdesivir
- +2 more
-
Dinajpur, BangladeshM. Abdur Rahim Medical College Hospital
Dec 31, 2020
COVID-19, SARS-CoV-2 Trial in Wuhan (Remdesivir, Remdesivir )
Suspended
- COVID-19
- SARS-CoV-2
- Remdesivir
- Remdesivir placebo
-
Wuhan, Hubei, ChinaJin Yin-tan hospital
Apr 13, 2020
COVID-19 Trial in Worldwide (Remdesivir, RDV Placebo, Standard of Care)
Terminated
- COVID-19
- Remdesivir
- +2 more
-
Birmingham, Alabama
- +62 more
Jun 1, 2022
CoVid 19 Positive Trial in Los Angeles (Hydroxychloroquine, Azithromycin, Hydroxychloroquine, Doxycycline, Hydroxychloroquine,
Completed
- CoVid 19 Positive
- Hydroxychloroquine, Azithromycin
- +10 more
-
Los Angeles, CaliforniaFHHI-OI-Camelot; QME
Nov 10, 2020
Covid19, Cytokine Release Syndrome, Critical Illness Trial in Rawalpindi (procedure, biological, drug)
Completed
- Covid19
- +3 more
- Therapeutic Plasma exchange
- +4 more
-
Rawalpindi, Punjab, PakistanPak Emirates Military Hospital
Jul 28, 2020
SARS-CoV Infection, COVID 19, Acute Respiratory Distress Syndrome ARDS Trial in Oslo (Hydroxychloroquine, Remdesivir, (Standard
Unknown status
- SARS-CoV Infection
- +2 more
- Hydroxychloroquine
- +2 more
-
Oslo, NorwayAndreas Barratt-Due
Apr 10, 2020
COVID-19 Trial in Austria (Chloroquine or Hydroxychloroquine, Lopinavir/Ritonavir, Best standard of care)
Recruiting
- COVID-19
- Chloroquine or Hydroxychloroquine
- +11 more
-
Innsbruck, Tirol, Austria
- +8 more
Feb 25, 2021
Coronavirus Disease 2019 (COVID-19), Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Trial in United States
Terminated
- Coronavirus Disease 2019 (COVID-19)
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- anti-CD14
- +2 more
-
Torrance, California
- +13 more
Mar 24, 2022
SARS-CoV-2 Infection, COVID-19, Moderate and Severe COVID-19 Trial in Germany (Standard of Care (SoC), Remdesivir)
Active, not recruiting
- SARS-CoV-2 Infection
- +2 more
- Standard of Care (SoC)
- Remdesivir
-
Bremen, Germany
- +3 more
Oct 2, 2020
Covid19 Trial in Philippines (Remdesivir, Hydroxychloroquine, Lopinavir / Ritonavir)
Completed
- Covid19
- Remdesivir
- +4 more
-
Baguio City, Benguet, Philippines
- +24 more
Feb 27, 2022
COVID, COVID-19, SARS-CoV-2 Trial in Worldwide (biological, other, drug)
Completed
- COVID
- +3 more
- Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG)
- +2 more
-
Colorado Springs, Colorado
- +38 more
Mar 31, 2022
COVID-19 Trial in United States (Remdesivir, Pulmozyme, IC14)
Recruiting
- COVID-19
- Remdesivir
- +6 more
-
Birmingham, Alabama
- +18 more
Jul 19, 2021
Covid19 Trial in Brazil, United States (Remdesivir, Remdesivir Placebo, Aviptadil)
Active, not recruiting
- Covid19
- Remdesivir
- +4 more
-
Tucson, Arizona
- +54 more
Aug 12, 2022
COVID-19 Trial in Worldwide (Remdesivir, Standard of Care)
Completed
- COVID-19
- Remdesivir
- Standard of Care
-
Anaheim, California
- +183 more
Jan 21, 2021
COVID-19 Trial in Worldwide (Remdesivir, Standard of Care)
Completed
- COVID-19
- Remdesivir
- Standard of Care
-
Anaheim, California
- +182 more
Dec 15, 2020